165 related articles for article (PubMed ID: 19495935)
1. MDV-1 VP22: a transporter that can selectively deliver proteins into cells.
Zhang C; Qin A; Chen H; Deng X; Su Y; Qian K
Arch Virol; 2009; 154(7):1027-34. PubMed ID: 19495935
[TBL] [Abstract][Full Text] [Related]
2. [The N1-18 terminus of Marek's disease virus VP22 is essential for protein transduction].
Chen H; Qin A; Song C; Zhang C; Deng X
Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):91-7. PubMed ID: 18338583
[TBL] [Abstract][Full Text] [Related]
3. MDV-1 VP22 conjugated VP2 enhancing immune response against infectious bursal disease virus by DNA vaccination in mice.
Chen H; Zhang C; Song C; Deng X; Qin A
Sci China C Life Sci; 2008 Nov; 51(11):981-6. PubMed ID: 18989640
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and immunological characterization of monoclonal antibodies against VP22 carboxyl terminus of Marek's disease virus serotype 1].
Song CP; Chen HJ; Qin AJ; Zhang CF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):249-52. PubMed ID: 17343794
[TBL] [Abstract][Full Text] [Related]
5. Marek's disease virus VP22: subcellular localization and characterization of carboxyl terminal deletion Mutations.
O'Donnell LA; Clemmer JA; Czymmek K; Schmidt CJ
Virology; 2002 Jan; 292(2):235-40. PubMed ID: 11878926
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the nuclear localization and nuclear export signals of bovine herpesvirus 1 VP22.
Zheng C; Brownlie R; Babiuk LA; van Drunen Littel-van den Hurk S
J Virol; 2005 Sep; 79(18):11864-72. PubMed ID: 16140763
[TBL] [Abstract][Full Text] [Related]
7. Evidence that Marek's disease virus exists in a latent state in a sustainable fibroblast cell line.
Abujoub AA; Coussens PM
Virology; 1997 Mar; 229(2):309-21. PubMed ID: 9126245
[TBL] [Abstract][Full Text] [Related]
8. Intercellular trafficking of the major tegument protein VP22 of bovine herpesvirus-1 and its application to improve a DNA vaccine.
Zheng CF; Brownlie R; Huang DY; Babiuk LA; van Drunen Littel-van den Hurk S
Arch Virol; 2006 May; 151(5):985-93. PubMed ID: 16374718
[TBL] [Abstract][Full Text] [Related]
9. Intercellular spread of GFP-VP22.
Aints A; Dilber MS; Smith CI
J Gene Med; 1999; 1(4):275-9. PubMed ID: 10738560
[TBL] [Abstract][Full Text] [Related]
10. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent tagging of VP22 in N-terminus reveals that VP22 favors Marek's disease virus (MDV) virulence in chickens and allows morphogenesis study in MD tumor cells.
Rémy S; Blondeau C; Le Vern Y; Lemesle M; Vautherot JF; Denesvre C
Vet Res; 2013 Dec; 44(1):125. PubMed ID: 24359464
[TBL] [Abstract][Full Text] [Related]
12. Intercellular trafficking of VP22-GFP fusion proteins.
Elliott G; O'Hare P
Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
[TBL] [Abstract][Full Text] [Related]
13. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
[TBL] [Abstract][Full Text] [Related]
14. Characterization and localization of the unique Marek's disease virus type 2 ORF873 gene product.
Jang HK
J Vet Sci; 2004 Sep; 5(3):207-13. PubMed ID: 15365234
[TBL] [Abstract][Full Text] [Related]
15. Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16.
Dorange F; El Mehdaoui S; Pichon C; Coursaget P; Vautherot JF
J Gen Virol; 2000 Sep; 81(Pt 9):2219-2230. PubMed ID: 10950980
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
Roeder GE; Parish JL; Stern PL; Gaston K
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
[TBL] [Abstract][Full Text] [Related]
17. [Differentiation of recombinant adenoviruses expressed MDV-1 VP22 subcellular localization pattern].
Zhang CF; Qin AJ; Chen JJ; Qian K; DU J; Yin TY; Shao HX; Jin WJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Sep; 25(9):787-90. PubMed ID: 19737462
[TBL] [Abstract][Full Text] [Related]
18. Improving the potency of DNA vaccine against chicken anemia virus (CAV) by fusing VP1 protein of CAV to Marek's Disease Virus (MDV) type-1 VP22 protein.
Moeini H; Omar AR; Rahim RA; Yusoff K
Virol J; 2011 Mar; 8():119. PubMed ID: 21401953
[TBL] [Abstract][Full Text] [Related]
19. Identification of Marek's Disease Virus VP22 Tegument Protein Domains Essential for Virus Cell-to-Cell Spread, Nuclear Localization, Histone Association and Cell-Cycle Arrest.
Trapp-Fragnet L; Courvoisier K; Rémy S; Pape GL; Loustalot F; Denesvre C
Viruses; 2019 Jun; 11(6):. PubMed ID: 31181775
[TBL] [Abstract][Full Text] [Related]
20. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
